Lodo: Accelerator Life Science Partners' Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.
Accelerator Life Science Partners ("ALSP"), a leading early-stage life science accelerator and investment firm, today announced that its portfolio company, Lodo Therapeutics Corporation ("Lodo" or the "Company"), has been acquired by Zymergen Inc. (NASDAQ: ZY) for an undisclosed amount.
Read full article »
Lodo Therapeutics is a New York-based biotechnology firm that discovers and develops novel therapeutics for the treatment of patients with cancer.
Read more